10.71
0.05 (0.47%)
| Previous Close | 10.66 |
| Open | 10.55 |
| Volume | 253,652 |
| Avg. Volume (3M) | 359,626 |
| Market Cap | 1,532,001,280 |
| Price / Earnings (TTM) | 6.38 |
| Price / Earnings (Forward) | 6.69 |
| Price / Sales | 0.300 |
| Price / Book | 1.49 |
| 52 Weeks Range | |
| Earnings Date | 5 Aug 2025 |
| Profit Margin | 3.73% |
| Operating Margin (TTM) | 4.48% |
| Diluted EPS (TTM) | 1.68 |
| Quarterly Revenue Growth (YOY) | 4.00% |
| Quarterly Earnings Growth (YOY) | 53.00% |
| Total Debt/Equity (MRQ) | 145.79% |
| Current Ratio (MRQ) | 2.12 |
| Operating Cash Flow (TTM) | 304.93 M |
| Levered Free Cash Flow (TTM) | 41.04 M |
| Return on Assets (TTM) | 5.22% |
| Return on Equity (TTM) | 23.35% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Bearish |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | Ardent Health, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | 3.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | -1.5 |
| Technical Oscillators | 2.0 |
| Average | 1.00 |
|
Ardent Health Partners Inc is an operator of hospitals and a provider of healthcare services in the United States. It provide both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. The company has one reportable segment: healthcare services that provides healthcare services primarily through its ownership and operation of hospitals, certain of which provide related healthcare services through physician practices, outpatient centers, and post-acute facilities. Ardent has 30 acute care hospitals, more than 200 sites of care that operates across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Core |
| % Held by Insiders | 23.14% |
| % Held by Institutions | 73.31% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Chai Trust Co Llc | 31 Mar 2025 | 77,246,499 |
| Ventas, Inc. | 31 Dec 2024 | 9,342,501 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 20.00 (Keybanc, 86.74%) | Buy |
| Median | 16.00 (49.39%) | |
| Low | 14.60 (B of A Securities, 36.32%) | Sell |
| Average | 16.65 (55.46%) | |
| Total | 2 Buy, 1 Hold, 1 Sell | |
| Avg. Price @ Call | 12.14 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| UBS | 10 Sep 2025 | 17.00 (58.73%) | Buy | 13.03 |
| JP Morgan | 11 Aug 2025 | 15.00 (40.06%) | Hold | 12.04 |
| Keybanc | 07 Aug 2025 | 20.00 (86.74%) | Buy | 11.47 |
| B of A Securities | 16 Jul 2025 | 14.60 (36.32%) | Sell | 12.01 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 25 Aug 2025 | Announcement | Ardent Health to Participate in September Investor Conferences |
| 05 Aug 2025 | Announcement | Ardent Health Reports Second Quarter 2025 Results |
| 22 Jul 2025 | Announcement | Ardent Health Announces Second Quarter 2025 Results Conference Call and Webcast Date |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |